Associate Director of National Intelligence and Chief Information Officer

Fast-Tracking Drug Development and Scale-Up in the Post-Covid World, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, May 15, 2023
Associate Director of National Intelligence and Chief Information Officer, Drug development, BST, Pharmaceutical industry, COVID-19

TORONTO, Ontario, Canada, May 15, 2023 /PRNewswire-PRWeb/ -- Curia's Approach to Rapid Scale up and Development

Key Points: 
  • In this free webinar, learn about truncating drug development timelines in the aftermath of Covid.
  • The featured speaker will lay emphasis on phase-appropriate development, offering creative solutions and round the clock development across various continents.
  • The webinar will focus on truncating drug development timelines in the aftermath of Covid.
  • Join this webinar to learn how to accelerate drug development timelines in the post-Covid era.

Wolters Kluwer Experts to Share Financial Risk Insights With Vietnam’s Regulatory Leaders

Retrieved on: 
Monday, May 15, 2023
Legal, Technology, Finance, Banking, Accounting, Professional Services, Software, Data Analytics, Data Management, Asset Management, State Bank of Vietnam, Associate Director of National Intelligence and Chief Information Officer, FRR, Treasury, Digital technology, ALM, Bank, IEC, State bank, ESG, Commercial, Hotel Meliá, Melia, International Principles on the Application of Human Rights to Communications Surveillance, Risk management

Experts from Wolters Kluwer Finance, Risk & Regulatory Reporting (FRR) will offer insights at the “Transforming and Improving Financial Risk Management with International Principles and Standards” event taking place on Tuesday, May 16, at the Melia Hotel in Hanoi.

Key Points: 
  • Experts from Wolters Kluwer Finance, Risk & Regulatory Reporting (FRR) will offer insights at the “Transforming and Improving Financial Risk Management with International Principles and Standards” event taking place on Tuesday, May 16, at the Melia Hotel in Hanoi.
  • The conference is co-hosted by leadership from Vietnam’s Central Economic Commission, along with leadership from the State Bank of Vietnam.
  • Wolters Kluwer and IEC Group are co-organizers of the conference.
  • Wolters Kluwer FRR, which is part of the company’s Corporate Performance & ESG division, is a global market leader in the provision of integrated regulatory compliance and reporting solutions.

Moving Cell and Gene Therapy Trials into the Community: Challenges and Opportunities, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, May 11, 2023
Associate Director of National Intelligence and Chief Information Officer, Communication, Series, Senior, Research, Strategic management, Corporation, MPH, Fatigue, Nursing, Management, Parexel, Doctor of Philosophy, New Medicines

TORONTO, May 11, 2023 /PRNewswire-PRWeb/ -- Thanks to scientific advances and resource investment, the cell and gene therapy pipeline continues to expand. Current research infrastructure, however, cannot support the increased clinical development. The use of exploratory endpoints is growing, and often, small patient populations are difficult to identify, alongside challenges with recruiting diverse patient populations. Meanwhile, sites are understaffed and overwhelmed.

Key Points: 
  • In this free webinar, learn how moving cell and gene therapy trials from overloaded research centers to communities can increase diversity, expand patient access and relieve site fatigue.
  • TORONTO, May 11, 2023 /PRNewswire-PRWeb/ -- Thanks to scientific advances and resource investment, the cell and gene therapy pipeline continues to expand.
  • Learn practical guidance and actionable insight for addressing the complexity of study start-up and execution outside the traditional cell and gene therapy sites.
  • Join this webinar to learn how moving cell and gene therapy trials from overloaded research centers to communities can increase diversity, expand patient access and relieve site fatigue.

AskBio Announces 11 Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting in 2023

Retrieved on: 
Thursday, May 11, 2023
Muscular dystrophy, Huntington's disease, Associate Director of National Intelligence and Chief Information Officer, Gene, CC, Heart, Bayer, Assay, Genetic diversity, Multiple system atrophy, Glycogen storage disease type II, Research, AAV, RESEARCH, Innate resistance to HIV, FKRP, Parkinson's disease, Poster, Patient, Annual general meeting, Cell, ISCB Senior Scientist Award, Mouse, R, American Society of Gene and Cell Therapy, Society, BB, Library, AA, PARK, Kinetics, Vaccine, Pharmaceutical industry, Fine chemical

AskBio presentations cover pre-clinical research into immune responses to AAV, data on methods to improve the efficacy of AAV-gene therapy and research into improved analytics and bioassays.

Key Points: 
  • AskBio presentations cover pre-clinical research into immune responses to AAV, data on methods to improve the efficacy of AAV-gene therapy and research into improved analytics and bioassays.
  • By targeting these therapy areas, AskBio aims to deliver breakthrough treatments that could benefit more than 35 million patients worldwide.1–7
    AskBio's presentations at ASGCT include:
    A Platform Approach for Adeno-Associated Virus Manufacturing to Support Gene Therapy Products.
  • Presented by Audry Fernandez, R&D, Asklepios BioPharmaceutical, Inc. [Oral presentation: 16:00 May 18 (Room 411)]
    Impact of Genetic Diversity on Gene Therapy Efficacy.
  • Presented by Sandro Alves, Head preclinical (France), Asklepios BioPharmaceutical, Inc. [Poster presentation: 12:00 May 19 (Poster #1261)]

Rapid RTSM Configurations via Axiom Fusion RTSM Module - Clinical Trial Supply West Coast 2023

Retrieved on: 
Monday, May 8, 2023
Associate Director of National Intelligence and Chief Information Officer, Clinical data management, Fusion, Booth, Metric, IRT, Suite, Clinical trial, Coffee, Axiom, Pharmaceutical industry, Medical device

TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), the premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at Clinical Trial Supply West Coast 2023, May 9-10 in Burlingame, CA.

Key Points: 
  • TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), the premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at Clinical Trial Supply West Coast 2023, May 9-10 in Burlingame, CA.
  • The Clinical Trial Supply series provides a distinctive opportunity for clinical trial sponsors and solution providers to collaborate and explore solutions to overcome challenges related to clinical trial supply chain management.
  • With its integrated Randomization and Trial Supply Management (RTSM) solution, it offers efficient drug supply tracking, patient cohort management and randomization.
  • Fusion is user-friendly and offers advanced features to streamline the clinical trial process, helping researchers to manage drug supply effectively and speed up study timelines.

Swoop Celebrates Return of Non-Stop Flights to Orlando International Airport

Retrieved on: 
Monday, May 8, 2023
Orlando International Airport, Communication, Associate Director of National Intelligence and Chief Information Officer, Greater Orlando Aviation Authority, John C. Munro Hamilton International Airport, Marketing, Customer experience, MCO, ULCC, Airline, Tourism, Swoop, Hamiltonian

HAMILTON, ON, May 8, 2023 /CNW/ - On Saturday, Swoop, Canada's leading ultra-low-cost airline, celebrated its first flight since 2020 to Orlando International Airport (MCO).

Key Points: 
  • HAMILTON, ON, May 8, 2023 /CNW/ - On Saturday, Swoop, Canada's leading ultra-low-cost airline, celebrated its first flight since 2020 to Orlando International Airport (MCO).
  • "As Canada's number one sun-flying ultra-low-cost airline, we are thrilled to offer our Hamiltonian's year-round flights to Orlando International Airport," said Bob Cummings, President of Swoop.
  • "We're thrilled that travellers can continue to take advantage of ultra-low-cost flights to Florida this summer as Swoop resumes its service between Hamilton and Orlando International Airport (MCO).
  • - Colleen Ryan - Associate Director, Marketing, Communications & Customer Experience
    "Orlando International warmly welcomes the return of Swoop passengers and is glad Swoop is resuming its service," said Vicki Jaramillo, Chief Development Officer for the Greater Orlando Aviation Authority, which operates Orlando International Airport.

Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting

Retrieved on: 
Tuesday, May 2, 2023
Abstract, Associate Director of National Intelligence and Chief Information Officer, Gene, Activity, Doctor of Philosophy, MPV, Los Angeles Convention Center, American Society of Gene and Cell Therapy, Translational medicine, Patient, Cell, ISCB Senior Scientist Award, Development, Poster, Society, Computational biology, Vaccine

PHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that Samik Basu, M.D., Chief Scientific Officer at Cabaletta Bio, will deliver an invited, oral presentation titled “CD 19 CAR T-cells for SLE” as part of the session titled “Immune Effector Cells: 2023 and Beyond!” on Tuesday, May 16, 2023, at 11:05 a.m. PT at the upcoming American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, which is being held at the Los Angeles Convention Center in Los Angeles, CA from May 16-20, 2023.

Key Points: 
  • PHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that Samik Basu, M.D., Chief Scientific Officer at Cabaletta Bio, will deliver an invited, oral presentation titled “CD 19 CAR T-cells for SLE” as part of the session titled “Immune Effector Cells: 2023 and Beyond!” on Tuesday, May 16, 2023, at 11:05 a.m. PT at the upcoming American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, which is being held at the Los Angeles Convention Center in Los Angeles, CA from May 16-20, 2023.
  • In addition, new preclinical data for CABA-201, a 4-1BB-containing fully human CD19-CAR T cell investigational therapy, and updated clinical and translational data from the ongoing DesCAARTes™ trial for DSG3-CAART in adults with mucosal-dominant pemphigus vulgaris (mPV) will be presented in poster presentations.
  • Details of the poster presentations are as follows:
    Title: Preclinical Specificity and Activity of CABA-201, a Fully Human 4-1BB Containing CD19 CAR T Therapy for Treatment-Resistant Autoimmune Disease
    Presenter: Jinmin Lee, Ph.D., Associate Director, Preclinical Research and Jason Peng, Ph.D., Senior Scientist at Cabaletta Bio
    Presenter: Jenell Volkov, Ph.D., Director, Translational Medicine and Daniel Nunez, Ph.D., Associate Director, Computational Biology at Cabaletta Bio
    Additional information, including the accepted abstracts, can be accessed on the ASGCT website .
  • Presentation materials will be made available on the Posters & Publications section of the Company’s website following the event.

Voyager Therapeutics Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting

Retrieved on: 
Tuesday, May 2, 2023
Abstract, Associate Director of National Intelligence and Chief Information Officer, Capsid, Senior, PT, Brain, AAV, CNS, Discovery, BBB, Kalev Raave, ISCB Senior Scientist Award, Mouse, Therapy, Neurology, Society, Vaccine, Platinum, Communications satellite, Research

CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced seven data presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, taking place May 16-20, 2023, in Los Angeles.

Key Points: 
  • CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced seven data presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, taking place May 16-20, 2023, in Los Angeles.
  • Oral Presentation: Directed evolution of an AAV9 library identifies a capsid variant with enhanced brain tropism and liver de-targeting in non-human primates and mice following systemic administration.
  • Thursday, May 18, 2023, 2:15 p.m. PT - 2:30 p.m. PT.
  • Poster Presentation: Development of AAV-GBA1 gene replacement therapy via single-IV-delivery with a blood brain barrier penetrant AAV capsid.

Announcing a New Series of Director Training Workshops: Developing Property Management Expertise at Cusick Community Management

Retrieved on: 
Tuesday, May 2, 2023
Insurance, Communication, Checklist, Maintenance, Rock Hill, Policy, CINC, Associate Director of National Intelligence and Chief Information Officer, Community, Community management, Software, Management, Property management, HOA

CHARLOTTE, N.C., May 2, 2023 /PRNewswire-PRWeb/ -- Cusick Community Management delivered a series of workshops in Q1 2023, implementing new processes and procedures company-wide to equip their Association Directors with the tools and resources to provide optimal management of the 200+ homeowner associations they serve in North and South Carolina. These standards provide continuity of essential services and training for all Directors. A company-wide meeting is planned for the end of April to strengthen the Cusick team and share plans to meet the company's growth potential.

Key Points: 
  • Cusick Community Management promoted Saundra Roland to Procedural Compliance Director.
  • At the direction of Vice President Janette Parker, Ms. Roland has coordinated this series of Director Training Workshops detailing new technology and services.
  • The goal is to have these teams for every association that Cusick Community Management serves.
  • On Law Day, two attorneys (from North and South Carolina) shared current and upcoming legal issues that may impact community management to protect the 200+ HOAs managed by Cusick, their Boards of Directors and Cusick Community Management, itself.

York University leads $318.4M first-of-kind inclusive next-gen technology research initiative

Retrieved on: 
Friday, April 28, 2023
Psychology, Digital divide, Intellectual property, Associate Director of National Intelligence and Chief Information Officer, Human, Partnership, Life, Education, Culture, University, Connected, Ageing, York University, Intelligence, Mind, Humanities, Research, Innovation, Privacy, History, Associate, Indigenous Knowledge Centre, Science, Philosophy, Social justice, Hospital, DEDI, Computational neuroscience, Responsible Research and Innovation, UN, Engineering, Artificial intelligence, Virtual reality, Indigenous self-government in Canada, Knowledge, AI, Health, Osgoode Hall Law School, Management, Neuroscience

York University researchers believe it must be and have set out to make it so through a first of its kind interdisciplinary research initiative called Connected Minds: Neural and Machine Systems for a Healthy, Just Society .

Key Points: 
  • York University researchers believe it must be and have set out to make it so through a first of its kind interdisciplinary research initiative called Connected Minds: Neural and Machine Systems for a Healthy, Just Society .
  • Connected Minds has received a combined $105.7 million from the Canada First Research Excellence Fund (CFREF) , announced earlier today by the Government of Canada.
  • Of that, York received $82.8 million and institutional partner Queen’s University received $22.8 million.
  • Led by York, Connected Minds brings together experts in multiple fields, including humanities, engineering, law, and life sciences, located across eight York Faculties and three Queen’s Faculties.